China Healthwise FY26 H1 net loss widens to HK$ 29.09 million; revenue falls 29% to HK$ 36.46 million

• China Healthwise swung to a net loss attributable to owners of HK$29.09 million, with basic loss per share of 3.78 Hong Kong cents.
• Revenue fell 29% to HK$36.46 million, with gross margin dropping to about 13% from about 32%.
• Loss before tax widened to HK$30.34 million, hit by a HK$4.69 million fair-value loss on financial assets at FVTPL.
• Investment in financial instruments posted a segment loss before tax of HK$16.71 million, driven by HK$11.74 million loss on disposal.
• Subsequent events included a HK$10.79 million share subscription at HK$0.07 per share, with a 1-for-5 share consolidation proposed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Healthwise Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260827-12303571), on August 27, 2026, and is solely responsible for the information contained therein.